The National Agency for Food and Drug Administration and Control (NAFDAC) has raised a public health alert over the circulation ...

The Subject Expert Committee (SEC) on Oncology and Hematology, functioning under the Central Drugs Standard Control ...

Amgen said on Monday its experimental therapy helped patients with advanced gastric cancer live longer when combined with ...

Chemotherapy drugs in over 100 countries fail quality tests, putting cancer patients at risk of ineffective treatments.

Vital chemotherapy drugs used around the world have failed quality tests, putting cancer patients in more than 100 countries ...

The DESTINY-Breast09 study, reported at ASCO, compared antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) and Roche's HER2 antibody, Perjeta (pertuzumab), to the widely used THP ...

June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and ...

Around one fifth of generic cancer medication samples tested by the University of Notre Dame fail quality tests.

Discover the latest updates to the EAU guidelines for muscle-invasive and metastatic bladder cancer in 2025. Learn more.

The worst-performing drug in the study is made by Indian manufacturer Venus Remedies. It is called cyclophosphamide, a drug ...

As practicing oncologists, we can get bogged down in our individual practices and thus have trouble seeing the bigger picture ...